🕒 Wednesday 23 September 2026 Wed, 23 Sept 2026

Dundas Minerals has extended interpreted gold mineralisation at Rockland to about 170 metres below surface, led by a 4-metre interval grading 4.87 g/t gold. The early results strengthen the geological case for a 1-kilometre mineralised trend, but one-metre verification assays and more drilling are still required.

QMines has reported a broad 44-metre copper intersection and high-grade zinc-lead-gold-silver mineralisation from six holes at Mt Chalmers. The results support ongoing Definitive Feasibility Study work, while a hole ending in copper mineralisation and upcoming barge drilling add further exploration interest.

Aurum Resources has secured A$52.5 million from institutional investors to begin long-lead procurement and other early works at its Boundiali gold project before the definitive feasibility study is complete. The raise strengthens the balance sheet, but also adds 95.45 million shares ahead of two major technical milestones.

West Cobar Metals has engaged Wallis Drilling for its first scandium-focused campaign at the Salazar project, with work targeted for October subject to approvals. The programme will test shallow saprolite for higher-grade scandium zones and extensions to existing rare earth and titanium dioxide resources.

Minerals Exploration has intersected broad, lower-grade gold mineralisation with higher-grade structures in four holes at Jubilee South, expanding the interpreted system toward Sovereign. The company is preparing a six-hole, 1,200-metre Sovereign program, subject to approvals, while caution remains around recovery and unproven continuity.

Silver Mines has secured firm commitments for a $70 million placement, giving the company more funding to advance its Bowdens Silver Project through development approvals and engineering studies. The raise also supports royalty acquisitions, exploration and land access, although nearly 43% of the new shares still require shareholder approval.

Frontier Digital Ventures has shrunk its top line by 27% as it exits low-margin businesses, but the reset delivered higher EBITDA, a 17% margin and near-total free cash flow conversion in the first half of FY2026. The next test is whether pricing and cost discipline can lift earnings without further customer erosion.

Investigator Silver has begun a fully funded 30,000-metre drilling campaign at its Paris Silver Project in South Australia, targeting resource growth and extensions beyond the current mine plan. Assay results will arrive progressively, making the next few months a test of whether recent high-grade hits can translate into a larger, higher-confidence mineral inventory.

Anax Metals has reported broad, high-grade copper-equivalent intersections at Mons Cupri, including 85.90 metres at 2.89% CuEq. The results support the existing resource model and early mining sequence as Anax works towards financing, FEED completion and a potential Final Investment Decision.

Ausgold has secured an ASX waiver allowing 6,000,004 vested unlisted warrants to be cancelled without a separate shareholder vote if OceanaGold’s proposed takeover scheme becomes effective. The unexercised warrants would instead convert into Ausgold shares eligible to participate in the scheme.

Delorean Corporation and Opal have completed the concept stage for a proposed anaerobic digestion facility at Opal’s Maryvale Mill in Victoria. The project could replace natural gas used by the mill’s rotary lime kiln, but still requires further engineering, commercial work and a final investment decision.

Synertec has raised its FY27 revenue guidance by $8.0 million to $8.3 million, pointing to stronger contract conversion and visibility across its Engineering and Powerhouse businesses. The upgrade follows the $45.5 million ANSTO nuclear medicine manufacturing contract, but covers revenue only and not earnings or cash flow.

Southern Cross Gold’s Sunday Creek project has cleared its first formal mining licence hurdle, with Resources Victoria accepting a 30.7-hectare application covering the Golden Dyke workings. The milestone begins a public assessment process, but does not yet authorise mining.

Australian Mines has appointed a specialist consultant team to complete the pre-feasibility study for its Flemington Scandium Project, targeting delivery in the first quarter of 2027. The study will retain a 60-tonne-per-year scandium oxide reference case while testing production scenarios of up to 180 tonnes per year.

Perpetual Resources has added 62 lode claims around its Nevada Scheelite tungsten project, expanding the land position by 1,271.63 acres and more than 15 times the original patented claim area. The move broadens the project from a historic mine redevelopment opportunity into a larger exploration play, although the new ground remains untested.

Paradigm Biopharmaceuticals has secured a voluntary suspension of its ASX securities while it prepares to release interim analysis results from its PARA_OA_012 Phase 3 trial. The announcement gives no indication whether the clinical readout is favourable or unfavourable, with trading potentially resuming on 28 September subject to ASX approval.

Leeuwin Metals has confirmed gold across all 10 samples from historic tailings at its Marda Central project, averaging 0.596 g/t Au in the top metre. The result points to a potentially accessible processing opportunity, but the material remains well short of a defined resource or economic study.

Trek Metals has completed its maiden Phase 1 drilling campaign at Kuro, with 38 of 72 holes returning significant manganese and several high-grade shallow intersections. Phase 2 assays are now the next test of whether the system extends beyond the initial discovery area.

Patrys has dosed the first participants in the Phase 1a trial of RLS-2202, moving its intravenous quetiapine formulation into human clinical evaluation. The next test comes in October, when an independent safety committee will decide whether the program can advance to Cohort 2.

Patagonia Lithium has reported 15% total porosity and substantial free-fluid storage from Cilon Well 8, strengthening its interpretation of the aquifer’s pumping potential. The evidence is encouraging but remains incomplete, with four core results, further BMR Gamma data and a 72-hour pump test still outstanding.

Actinogen Medical has completed the final patient visit in its 247-participant XanaMIA Alzheimer’s disease trial, keeping topline results on track for November 2026. The milestone closes patient participation in the pivotal study, but provides no indication yet of whether Xanamem improved outcomes.

Riedel Resources has begun a 1,100-sample soil geochemistry program across its 580km² Cosmo Gold Project in Western Australia, targeting unexplored ground and existing gold anomalies. The work is designed to sharpen drill targets before the company’s maiden Cosmo drilling campaign, scheduled for October.

Global Lithium’s proposed acquisition of the Nova Operation from IGO has become unconditional after the ACCC waived its notification requirement. Completion is still pending the shutdown and final shipment timetable, with the transaction not yet completed.

Dimerix has drawn A$17 million from a non-dilutive facility, giving the biotech funding it says is sufficient to complete the ACTION3 Phase 3 trial of DMX-200 and continue developing DMX-652. A further A$17 million remains available, although repayment depends partly on future licensing income, milestones or capital-market access.